Experts discussed trends in clinical trial operations at the recent Outsourcing in Clinical Trials and Clinical Trials Supply ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

As these vectors progress to the next level of phase I and phase II clinical studies, it is important to establish vector purification schemes that are both amenable to large-scale production and ...

Adeno-associated viral vectors (AAV) have emerged as key players in this growth trajectory, projected to capture a ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Converting images into vector graphics or creating vector graphics is particularly useful if you need graphics for logos, illustrations, or print templates. While conventional image formats such ...

IMUNON (IMNN) announced the presentation of new clinical data from the recently completed Phase 2 OVATION 2 Study of IMNN-001, its ...

and the manufacturing of non-clinical and clinical materials of the viral vector. The produced lentivirus vector will be used as an intermediate product in the manufacturing of the final TCR-T ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

myvac is a viral vector (MVA—Modified Vaccinia Ankara ... TG4050 is the first myvac-derived product being evaluated in clinical trials. TG4050 is an individualized immunotherapy being developed for ...